Notice of Extension to PAR-22-193 "Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)"
Notice Number:
NOT-HL-25-014

Key Dates

Release Date:

May 21, 2025

Related Announcements

  • July 12, 2022 - Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required). See NOFO PAR-22-193. 

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform applicants that effective immediately the National Heart, Lung, and Blood Institute (NHLBI) is extending PAR-22-193 “Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)” by one Council round. 

The following text in bold and italics has been updated to reflect the extension:

Part 1. Overview Information

Key Dates

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDSScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
October 11, 2022November 10, 2022January 11, 2023March 2023May 2023July 2023
February 10, 2023March 10, 2023May 11, 2023July 2023October 2023December 2023
June 13, 2023July 11, 2023September 11, 2023November 2023January 2024April 2024
October 11, 2023November 13, 2023January 11, 2024March 2024May 2024July 2024
February 13, 2024March 11, 2024May 10, 2024July 2024October 2024December 2024
June 11, 2024July 11, 2024September 11, 2024November 2024January 2025April 2025
October 11, 2024November 12, 2024January 10, 2025March 2025May 2025July 2025
February 11, 2025March 11, 2025May 12, 2025July 2025October 2025December 2025
June 11, 2025July 11, 2025September 11, 2025November 2025January 2026April 2026
October 10, 2025November 10, 2025January 12, 2026March 2026May 2026July 2026

Expiration Date: January 12, 2026

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific/Research Contact(s)

Division of Blood Diseases and Resources
Division of Blood Diseases and Resources, Clinical Trials
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: PAR-22-193

Division of Cardiovascular Sciences
Yves Rosenberg, MD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-1292
Email: [email protected] 

Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: PAR-22-193

Center for Translation Research and Implementation Science
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: PAR-22-193

Financial/Grants Management Contact(s)
Office of Grants Management
National Heart, Lung, and Blood Institute (NHLBI) 
Email: [email protected]
Subject: PAR-22-193

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®